Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-25-000033 General Corporate
Debt relative to revenue 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
177.11% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.32% · OPTIONAL · VALID
Operating cash generation 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
27.69% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
23.41% · CORE · VALID
Gross margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.08% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-6.20% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.37% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
26.57% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 182.47%
Current 177.11%
Delta -5.35% Capex Intensity Decreased
Previous 2.71%
Current 2.32%
Delta -0.39% Cash Generation Decreased
Previous 52.76%
Current 27.69%
Delta -25.07% Growth Decreased
Previous 26.42%
Current 23.41%
Delta -3.01% Margin Decreased
Previous 77.47%
Current 77.08%
Delta -0.39% Profitability Decreased
Previous -4.88%
Current -6.20%
Delta -1.31% R And D Intensity Increased
Previous 24.56%
Current 26.37%
Delta 1.81% Sbc Intensity Increased
Previous 25.03%
Current 26.57%
Delta 1.54% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.